title: Angiographically Silent Macular Edema.
authors.affiliation: Department of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky.
authors.forename: Shivani V
authors.initials: SV
authors.lastname: Reddy
authors.affiliation: Robley Rex Veterans Affairs Medical Center, Louisville, Kentucky.
authors.forename: Shorye
authors.initials: S
authors.lastname: Payne
authors.affiliation: Department of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky.
authors.forename: Shlomit
authors.initials: S
authors.lastname: Schaal
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001803:Blood Transfusion / Q000379:methods; D000069286:Bortezomib / Q000008:administration & dosage; D003131:Combined Modality Therapy / Q000379:methods; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D005451:Fluorescein Angiography / Q000379:methods; D005500:Follow-Up Studies; D006801:Humans; D008269:Macular Edema / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D008297:Male; D009101:Multiple Myeloma / Q000150:complications* / Q000175:diagnosis; D010956:Plasmapheresis / Q000379:methods; D042262:Retinoscopy / Q000379:methods; D012720:Severity of Illness Index; D041623:Tomography, Optical Coherence / Q000379:methods; D016896:Treatment Outcome; D014786:Vision Disorders / Q000175:diagnosis / Q000209:etiology; D014792:Visual Acuity
chemical_list: D000069286:Bortezomib; D003907:Dexamethasone; D003520:Cyclophosphamide